Kobe, Mar 16, 2010 (JCN Newswire) - Sysmex Corporation (TSE: 6869) has started research jointly with the National Cancer Center Hospital to verify clinical usefulness of a technology developed by Sysmex for detecting living tumor cells suspended in blood (CTC detection technology).
